RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+9.18%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.19B
AUM Growth
+$4.19B
(+0.79%)
Cap. Flow
+$31.2M
Cap. Flow
% of AUM
0.75%
Top 10 Holdings %
Top 10 Hldgs %
34.6%
Holding
124
New
3
Increased
47
Reduced
8
Closed
3
Top Buys
| 1 |
Mineralys Therapeutics
MLYS
|
$18.3M |
| 2 |
Biomea Fusion
BMEA
|
$17.6M |
| 3 |
Revolution Medicines
RVMD
|
$15.2M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$14.5M |
| 5 |
Pliant Therapeutics
PLRX
|
$13.1M |
Top Sells
| 1 |
Baxter International
BAX
|
$58.6M |
| 2 |
Penumbra
PEN
|
$20.8M |
| 3 |
Align Technology
ALGN
|
$18.4M |
| 4 |
Immunocore
IMCR
|
$15.8M |
| 5 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$13.7M |
Sector Composition
| 1 | Healthcare | 97.18% |
| 2 | Consumer Staples | 1.05% |
| 3 | Industrials | 0.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
DexCom
DXCM
$29.5B
| $57M | 1.36% | 490,500 | – | – |
|
27
Akero Therapeutics
AKRO
$3.74B
| $55.6M | 1.33% | 1,454,254 +53,600 | +4% | +$2.05M |
|
28
Ultragenyx Pharmaceutical
RARE
$2.89B
| $53.6M | 1.28% | 1,336,401 +46,122 | +4% | +$1.85M |
|
29
Edwards Lifesciences
EW
$47.8B
| $53.4M | 1.27% | 645,900 | – | – |
|
30
Ascendis Pharma
ASND
$11.8B
| $45.6M | 1.09% | 425,500 | – | – |
|
31
Freshpet
FRPT
$2.72B
| $43.9M | 1.05% | 662,500 +5,500 | +0.8% | +$364K |
|
32
Mirum Pharmaceuticals
MIRM
$3.71B
| $43.1M | 1.03% | 1,795,733 | – | – |
|
33
Amylyx Pharmaceuticals
AMLX
$836M
| $42.6M | 1.02% | 1,452,816 +223,179 | +18% | +$6.55M |
|
34
Xenon Pharmaceuticals
XENE
$2.98B
| $42.2M | 1.01% | 1,178,002 +2,330 | +0.2% | +$83.4K |
|
35
Pacira BioSciences
PCRX
$1.2B
| $42.1M | 1.01% | 1,032,600 | – | – |
|
36
Phreesia
PHR
$1.88B
| $42.1M | 1% | 1,302,500 | – | – |
|
|
37
Biomea Fusion
BMEA
$116M
| $40.2M | 0.96% | 1,297,213 +566,367 | +77% | +$17.6M |
|
|
MRTX
38
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $39.6M | 0.95% | 1,065,261 +260,237 | +32% | +$9.68M |
|
|
NVRO
39
DELISTED
NEVRO CORP.
NVRO
| $39M | 0.93% | 1,077,900 | – | – |
|
40
iRhythm Technologies
IRTC
$5.46B
| $38.4M | 0.92% | 309,450 | – | – |
|
|
OLK
41
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $37.2M | 0.89% | 1,650,000 +205,000 | +14% | +$4.62M |
|
|
ACCD
42
DELISTED
Accolade, Inc. Common Stock
ACCD
| $36.6M | 0.87% | 2,545,000 +607,000 | +31% | +$8.73M |
|
43
Prothena Corp
PRTA
$441M
| $36.5M | 0.87% | 753,462 | – | – |
|
44
Kymera Therapeutics
KYMR
$2.95B
| $36.4M | 0.87% | 1,228,379 +600 | +0% | +$17.8K |
|
45
Zai Lab
ZLAB
$3.68B
| $35.2M | 0.84% | 1,059,700 | – | – |
|
46
Aclaris Therapeutics
ACRS
$209M
| $32.1M | 0.76% | 3,961,849 +600 | +0% | +$4.85K |
|
|
ABCM
47
DELISTED
Abcam plc American Depositary Shares
ABCM
| $30.2M | 0.72% | 2,242,500 +62,500 | +3% | +$841K |
|
48
Travere Therapeutics
TVTX
$1.56B
| $28.7M | 0.69% | 1,276,650 +325,000 | +34% | +$7.31M |
|
49
Rhythm Pharmaceuticals
RYTM
$6.85B
| $28.5M | 0.68% | 1,597,123 -163,742 | -9% | -$2.92M |
|
50
Health Care Select Sector SPDR Fund
XLV
$33.9B
| $25.9M | 0.62% | 200,000 | – | – |
|